Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose
- PMID: 18199133
- DOI: 10.1111/j.1464-5491.2007.02329.x
Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose
Abstract
Aims: To investigate changes in insulin action and insulin secretion in obese subjects with different categories of impaired glucose regulation (IGR): impaired glucose tolerance (IGT), impaired fasting glucose (IFG), and combined IFG/IGT (CGI).
Methods: A total of 222 subjects underwent an oral glucose tolerance test and a frequently sampled intravenous glucose tolerance test (FSIGTT); 100 had normal glucose tolerance (subdivided into 32 lean NGT, 68 obese NGT), and 122 were obese with IGR (82 IGT, 14 IFG and 26 CGI). The insulin sensitivity index (S(I)) was assessed by Bergman's minimal model method with FSIGTT; insulin secretion was determined by acute insulin response to glucose (AIRg). The disposition index (DI), the product of AIRg and S(I), was used to determine whether AIRg was adequate to compensate for insulin resistance.
Results: S(I) was similar in NGT and IGR obese subgroups. AIRg was significantly increased in obese NGT as compared with lean NGT, significantly reduced in IGT, and further reduced in IFG and CGI subjects as compared with obese NGT subgroups. DI was reduced in NGT obese individuals. Within the obese IGR subgroups, IFG and CGI subjects had even lower DI value than IGT subjects.
Conclusions: Obese Chinese subjects with IGR have a similar degree of insulin resistance but differ in insulin secretion. Subjects with IFG and CGI have a more prominent deficiency in insulin secretion than subjects with IGT.
Similar articles
-
Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.Endocrine. 2008 Aug-Dec;34(1-3):75-80. doi: 10.1007/s12020-008-9106-6. Epub 2008 Nov 1. Endocrine. 2008. PMID: 18979203
-
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8. Acta Diabetol. 2011. PMID: 21553243 Clinical Trial.
-
[A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].Zhonghua Yi Xue Za Zhi. 2003 Nov 25;83(22):1952-6. Zhonghua Yi Xue Za Zhi. 2003. PMID: 14703429 Chinese.
-
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.Diabetes Care. 2006 May;29(5):1130-9. doi: 10.2337/diacare.2951130. Diabetes Care. 2006. PMID: 16644654 Review.
-
[Insulin release kinetics and insulin sensitivity in impaired glucose tolerance].Nihon Rinsho. 1996 Oct;54(10):2658-66. Nihon Rinsho. 1996. PMID: 8914424 Review. Japanese.
Cited by
-
Low glucose transporter SLC2A5-inhibited human normal adjacent lung adenocarcinoma cytoplasmic pro-B cell development mechanism network.Mol Cell Biochem. 2015 Jan;399(1-2):71-6. doi: 10.1007/s11010-014-2233-x. Epub 2014 Oct 18. Mol Cell Biochem. 2015. PMID: 25326153
-
Prevalence and correlates of pre-diabetes in adults of mixed ethnicities in the South African population: A systematic review and meta-analysis.PLoS One. 2022 Nov 29;17(11):e0278347. doi: 10.1371/journal.pone.0278347. eCollection 2022. PLoS One. 2022. PMID: 36445923 Free PMC article.
-
Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men.Diabetes. 2009 May;58(5):1212-21. doi: 10.2337/db08-1607. Epub 2009 Feb 17. Diabetes. 2009. PMID: 19223598 Free PMC article.
-
Evidence of reduced β-cell function in Asian Indians with mild dysglycemia.Diabetes Care. 2013 Sep;36(9):2772-8. doi: 10.2337/dc12-2290. Epub 2013 Apr 17. Diabetes Care. 2013. PMID: 23596180 Free PMC article.
-
Evolution of the diagnostic value of "the sugar of the blood": hitting the sweet spot to identify alterations in glucose dynamics.Physiol Rev. 2023 Jan 1;103(1):7-30. doi: 10.1152/physrev.00015.2022. Epub 2022 May 30. Physiol Rev. 2023. PMID: 35635320 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical